1. Home
  2. WAVE vs EVAX Comparison

WAVE vs EVAX Comparison

Compare WAVE & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eco Wave Power Global AB (publ)

WAVE

Eco Wave Power Global AB (publ)

HOLD

Current Price

$7.98

Market Cap

29.4M

Sector

Utilities

ML Signal

HOLD

EVAX

Evaxion Biotech

HOLD

Current Price

$3.68

Market Cap

32.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WAVE
EVAX
Founded
2011
2008
Country
Israel
Denmark
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.4M
32.7M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
WAVE
EVAX
Price
$7.98
$3.68
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$11.67
AVG Volume (30 Days)
23.3K
29.4K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$436.84
N/A
Revenue Next Year
N/A
$328.20
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.52
$2.11
52 Week High
$10.50
$12.15

Technical Indicators

Market Signals
Indicator
WAVE
EVAX
Relative Strength Index (RSI) 41.05 42.55
Support Level $6.92 $3.35
Resistance Level $8.60 $4.57
Average True Range (ATR) 0.76 0.27
MACD -0.26 -0.03
Stochastic Oscillator 8.36 27.19

Price Performance

Historical Comparison
WAVE
EVAX

About WAVE Eco Wave Power Global AB (publ)

Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographical presence in Israel, USA and Mexico.

About EVAX Evaxion Biotech

Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.

Share on Social Networks: